LGND
HEALTHCARELigand Pharmaceuticals Incorporated
AI Insight
What's Moving LGND Today?
No stock-specific AI insight has been generated for LGND yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$111.72$276.20
$279.44
Fundamentals
Market Cap$5.3B
P/E Ratio34.1
EPS$7.68
Dividend Yield—
Dividend / Share—
ROE17.1%
Profit Margin55.9%
Debt / Equity—
Trading
Volume2.3M
Avg Volume (10D)—
Shares Outstanding20.0M
LGND News
24 articles- Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes OfferingYahoo Finance·Jun 23, 2026
- Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031Yahoo Finance·Jun 22, 2026
- Ligand Pharmaceuticals Director Unloads 2,501 Shares — Should You Be Concerned?Motley Fool·Jun 14, 2026
- Ligand Announces 2026 Investor Day in New York CityYahoo Finance·Jun 10, 2026
- A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 MillionThe Motley Fool·Jun 7, 2026
- How The Ligand Pharmaceuticals (LGND) Investment Story Is Evolving Without Fresh Analyst TargetsYahoo Finance·Jun 1, 2026
- Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy?Motley Fool·May 30, 2026
- OneSpaWorld Posted Record Revenue for Last Quarter. Why Did a Fund Exit a $21.5 Million Stake?Motley Fool·May 29, 2026
- Ligand to Participate in June Investor ConferencesYahoo Finance·May 27, 2026
- Is Genpact Stock a Buy After Hedge Fund Rice Hall James Raised Its Stake by $14 Million?Motley Fool·May 19, 2026
- Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares?Motley Fool·May 16, 2026
- Ligand Pharmaceuticals' (NASDAQ:LGND) Strong Earnings Are Of Good QualityYahoo Finance·May 15, 2026
- Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business UpdatesYahoo Finance·May 12, 2026
- Ligand (LGND) Q1 2026 Earnings Call TranscriptMotley Fool·May 12, 2026
- A Look At Ligand Pharmaceuticals (LGND) Valuation After Earnings Miss XOMA Deal And Viking TR-Beta TerminationYahoo Finance·May 12, 2026
- LGND: 1Q:26 Results Highlight Breadth of PortfolioYahoo Finance·May 11, 2026
- Ligand Pharmaceuticals Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- Ligand Reports First Quarter 2026 Financial ResultsYahoo Finance·May 7, 2026
- Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing AgreementYahoo Finance·May 6, 2026
- Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing AgreementYahoo Finance·May 6, 2026
- XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law FirmGlobeNewswire Inc.·Apr 28, 2026
- Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 MillionBenzinga·Apr 27, 2026
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of XOMA Royalty Corporation (NASDAQ: XOMA)GlobeNewswire Inc.·Apr 27, 2026
- Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to KnowThe Motley Fool·Mar 27, 2026
All 24 articles loaded
Price Data
Open$259.35
Previous Close$262.17
Day High$282.53
Day Low$258.00
52 Week High$276.20
52 Week Low$111.72
52-Week Range
$111.72$276.20
$279.44
Fundamentals
Market Cap$5.3B
P/E Ratio34.1
EPS$7.68
Dividend Yield—
Dividend / Share—
ROE17.1%
Profit Margin55.9%
Debt / Equity—
Trading
Volume2.3M
Avg Volume (10D)—
Shares Outstanding20.0M
About Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover and develop drugs globally. The company is headquartered in San Diego, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—